Facing a tepid Alzheimer’s market, Lilly looks to build ‘a sense of urgency’ to jumpstart sales of donanemab

On paper, Alzheimer’s disease should be an uncomplicated market for drugmakers. There are millions of potential patients, who until recently had no real option for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Balancing Innovation and the Ethical Adoption of AI in Healthcare

Andre Esteva, Founder and CEO of ArteraAI In recent years, the rapid advancement of artificial intelligence (AI) has created a wave of excitement and anticipation

September 6, 2023

CalmiGo Donates Exhalers to Help Survivors of Terrorist Attacks in Israel Cope with Anxiety and PTSD

What You Should Know: CalmiGo, a developer of the first and only drug-free device that empowers people suffering from anxiety, PTSD, and panic attacks with immediate

November 14, 2023

Hologic allies with Bayer to support uptake of contrast-enhanced mammography

Dive Brief: Hologic has partnered with Bayer to support the adoption of contrast-enhanced mammography (CEM) in parts of Asia Pacific, Canada and Europe. CEM entails

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.